Chromosomal aberrations and aneuploidy in oral potentially malignant lesions: distinctive features for tongue. 2011

Patrizio Castagnola, and Davide Malacarne, and Paola Scaruffi, and Massimo Maffei, and Alessandra Donadini, and Emanuela Di Nallo, and Simona Coco, and Gian Paolo Tonini, and Monica Pentenero, and Sergio Gandolfo, and Walter Giaretti
Department of Diagnostic Oncology, Translational Oncopathology, National Institute for Cancer Research, Genoa, Italy.

BACKGROUND The mucosae of the oral cavity are different at the histological level but appear all equally exposed to common genotoxic agents. As a result of this exposure, changes in the mucosal epithelia may develop giving rise to Oral Potentially Malignant Lesions (OPMLs), which with time may in turn progress to Oral Squamous Cell Carcinomas (OSCCs). Therefore, much effort should be devoted to identify features able to predict the likeliness of progression associated with an OPML. Such features may be helpful in assisting the clinician to establish both appropriate therapies and follow-up schedules. Here, we report a pilot study that compared the occurrence of DNA aneuploidy and chromosomal copy number aberrations (CNAs) in the OPMLs from different oral anatomical subsites. METHODS Samples from histologically diagnosed OPMLs were processed for high resolution DNA flow cytometry (hr DNA-FCM) in order to determine the relative DNA content expressed by the DNA index (DI). Additionally, array-Comparative Genomic Hybridization (a-CGH) analysis was performed on DNA obtained from diploid nuclei suspensions directly. When aneuploid nuclei were detected, these were physically separated from diploid nuclei on the base of their DI values by means of a DNA-FCM-Sorter in order to improve the a-CGH analysis. RESULTS Tongue OPMLs were more frequently associated with DNA aneuploidy and CNAs than OPMLs arising from all the other mucosal subsites. CONCLUSIONS We suggest that the follow-up and the management of the patients with tongue OPMLs should receive a distinctive special attention. Clearly, this hypothesis should be validated in a prospective clinical study.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D011230 Precancerous Conditions Pathological conditions that tend eventually to become malignant. Preneoplastic Conditions,Condition, Preneoplastic,Conditions, Preneoplastic,Preneoplastic Condition,Condition, Precancerous,Conditions, Precancerous,Precancerous Condition
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Patrizio Castagnola, and Davide Malacarne, and Paola Scaruffi, and Massimo Maffei, and Alessandra Donadini, and Emanuela Di Nallo, and Simona Coco, and Gian Paolo Tonini, and Monica Pentenero, and Sergio Gandolfo, and Walter Giaretti
April 2022, Journal of dental sciences,
Patrizio Castagnola, and Davide Malacarne, and Paola Scaruffi, and Massimo Maffei, and Alessandra Donadini, and Emanuela Di Nallo, and Simona Coco, and Gian Paolo Tonini, and Monica Pentenero, and Sergio Gandolfo, and Walter Giaretti
January 2021, Photobiomodulation, photomedicine, and laser surgery,
Patrizio Castagnola, and Davide Malacarne, and Paola Scaruffi, and Massimo Maffei, and Alessandra Donadini, and Emanuela Di Nallo, and Simona Coco, and Gian Paolo Tonini, and Monica Pentenero, and Sergio Gandolfo, and Walter Giaretti
January 2016, Einstein (Sao Paulo, Brazil),
Patrizio Castagnola, and Davide Malacarne, and Paola Scaruffi, and Massimo Maffei, and Alessandra Donadini, and Emanuela Di Nallo, and Simona Coco, and Gian Paolo Tonini, and Monica Pentenero, and Sergio Gandolfo, and Walter Giaretti
January 1994, European journal of cancer. Part B, Oral oncology,
Patrizio Castagnola, and Davide Malacarne, and Paola Scaruffi, and Massimo Maffei, and Alessandra Donadini, and Emanuela Di Nallo, and Simona Coco, and Gian Paolo Tonini, and Monica Pentenero, and Sergio Gandolfo, and Walter Giaretti
January 2015, Journal of oral biology and craniofacial research,
Patrizio Castagnola, and Davide Malacarne, and Paola Scaruffi, and Massimo Maffei, and Alessandra Donadini, and Emanuela Di Nallo, and Simona Coco, and Gian Paolo Tonini, and Monica Pentenero, and Sergio Gandolfo, and Walter Giaretti
June 1993, Community dental health,
Patrizio Castagnola, and Davide Malacarne, and Paola Scaruffi, and Massimo Maffei, and Alessandra Donadini, and Emanuela Di Nallo, and Simona Coco, and Gian Paolo Tonini, and Monica Pentenero, and Sergio Gandolfo, and Walter Giaretti
January 1970, Acta paediatrica Academiae Scientiarum Hungaricae,
Patrizio Castagnola, and Davide Malacarne, and Paola Scaruffi, and Massimo Maffei, and Alessandra Donadini, and Emanuela Di Nallo, and Simona Coco, and Gian Paolo Tonini, and Monica Pentenero, and Sergio Gandolfo, and Walter Giaretti
July 2023, Dentistry journal,
Patrizio Castagnola, and Davide Malacarne, and Paola Scaruffi, and Massimo Maffei, and Alessandra Donadini, and Emanuela Di Nallo, and Simona Coco, and Gian Paolo Tonini, and Monica Pentenero, and Sergio Gandolfo, and Walter Giaretti
January 2015, Journal of oral and maxillofacial pathology : JOMFP,
Patrizio Castagnola, and Davide Malacarne, and Paola Scaruffi, and Massimo Maffei, and Alessandra Donadini, and Emanuela Di Nallo, and Simona Coco, and Gian Paolo Tonini, and Monica Pentenero, and Sergio Gandolfo, and Walter Giaretti
March 1996, British journal of cancer,
Copied contents to your clipboard!